SavedAdd your journal

Journals / Health Sciences Quarterly / 2021 / Cilt: 5 - Sayı: 1

HOW ARE CARDIAC FUNCTIONS ALTERED IN PEDIATRIC PATIENTS RECEIVING ORAL IRON SUPPLEMENTATION DUE TO ANEMIA?

Merve HİÇYILMAZ
Ayhan PEKTAS
Selçuk GÜREL
Mehmet Bilgehan PEKTAŞ
Pages
81–92
Publication Date
2021-02-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The PR interval shortened significantly, p dispersion decreased significantly and T-peak to T-end interval shortened significantly following iron supplementation (respectively p=0.013, p=0.033 and p=0.029).Conclusion: Oral iron supplementation seems to contribute to the reversal of cardiac remodeling, elimination of compensatory hemodynamic mechanisms and inhibition of sympathetic activation within cardiac tissues

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aims to investigate whether oral iron supplementation improves structural and functional alterations by evaluating the echocardiography and electrocardiography findings of the pediatric patients with iron deficiency anemia.Methods: This is a prospective review of 30 pediatric patients who were diagnosed with iron deficiency anemia and received 12-week-long iron supplementation at the study center.
📊
Key Findings & Data:All children underwent hematological workup, detailed echocardiography examination and electrocardiography evaluation at the time of diagnosis for iron deficiency anemia andthe end of 12-week-long iron treatment.Results: After 12-week-long iron treatment, hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin concentration, red blood cell count, Mentzer index, serum iron, serum iron binding capacity, serum ferritin and transferrin increased significantly (p=0.001, p=0.001, p=0.001, p=0.036, p=0.001, p=0.002, p=0.001 and p=0.001 respectively).
💡
Conclusion & Impact:The PR interval shortened significantly, p dispersion decreased significantly and T-peak to T-end interval shortened significantly following iron supplementation (respectively p=0.013, p=0.033 and p=0.029).Conclusion: Oral iron supplementation seems to contribute to the reversal of cardiac remodeling, elimination of compensatory hemodynamic mechanisms and inhibition of sympathetic activation within cardiac tissues
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Child · Echocardiography · Electrocardiography

Abstract

Objective: This study aims to investigate whether oral iron supplementation improves structural and functional alterations by evaluating the echocardiography and electrocardiography findings of the pediatric patients with iron deficiency anemia.Methods: This is a prospective review of 30 pediatric patients who were diagnosed with iron deficiency anemia and received 12-week-long iron supplementation at the study center. All children underwent hematological workup, detailed echocardiography examination and electrocardiography evaluation at the time of diagnosis for iron deficiency anemia andthe end of 12-week-long iron treatment.Results: After 12-week-long iron treatment, hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin concentration, red blood cell count, Mentzer index, serum iron, serum iron binding capacity, serum ferritin and transferrin increased significantly (p=0.001, p=0.001, p=0.001, p=0.036, p=0.001, p=0.002, p=0.001 and p=0.001 respectively). Pulse rate, respiration rate, and diastolic left ventricle wall thickness decreased significantly while tricuspid E and A wave velocities increased significantly at the end of iron supplementation (p=0.004, p=0.033, p=0.009, p=0.003 and p=0.021 respectively). As for the tissue Doppler echocardiography findings, only interventricular septum isovolumetric contraction time decreased significantly after iron treatment (p=0.002). The PR interval shortened significantly, p dispersion decreased significantly and T-peak to T-end interval shortened significantly following iron supplementation (respectively p=0.013, p=0.033 and p=0.029).Conclusion: Oral iron supplementation seems to contribute to the reversal of cardiac remodeling, elimination of compensatory hemodynamic mechanisms and inhibition of sympathetic activation within cardiac tissues

🔖

Cite This Article

HİÇYILMAZ, M., PEKTAS, A., GÜREL, S., PEKTAŞ, M. B. (2021). HOW ARE CARDIAC FUNCTIONS ALTERED IN PEDIATRIC PATIENTS RECEIVING ORAL IRON SUPPLEMENTATION DUE TO ANEMIA?. Health Sciences Quarterly, Cilt: 5 - Sayı: 1, 81–92. https://ajindex.com/articles/836587

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. ALIOGLU, B., CETIN, I.I., EMEKSIZ, Z.S., DINDAR, N., TAPCI, E. & DALLAR, Y. (2013). Iron deficiency anemia in infants: Does it really affect the myocardial functions? Pediatric Hematology and Oncology, 30(3), 239–245.
  2. ANAND, I. S., GUPTA, P. (2018). Anemia and iron deficiency in heart failure. Circulation, 138(1), 80–98.
  3. ANKER, S.D., COMIN COLET, J., FILIPPATOS, G., WILLENHEIMER, R., DICKSTEIN, K., DREXLER, H., LÜSCHER, T.F., BART, B., BANASIAK, W., NIEGOWSKA, J., KIRWAN, B.A., MORI, C., VON EISENHART ROTHE, B., POCOCK, S.J., POOLE-WILSON, P.A., PONIKOWSKI, P. (2009). Ferric carboxymaltose in patients with heart failure and iron deficiency. New England Journal of Medicine, 361(25), 2436–2448.
  4. AVNI, T., LEIBOVICI, L., GAFTER-GVILI, A. (2012). Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. European Journal of Heart Failure, 14(4), 423–429.
  5. BAZETT, H.C. (1920). The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. The Journal of Physiology, 53(5), 320–339.
  6. CAMASCHELLA, C. (2015). Iron-deficiency anemia. New England Journal of Medicine, 372(19), 1832–1843.
  7. COHEN-SOLAL, A., DAMY, T., TERBAH, M., KEREBEL, S., BAGUET, J.P., HANON, O., ZANNAD, F., LAPERCHE, T., LECLERCQ, C., CONCAS, V., DUVILLIÉ, L., DARNÉ, B., ANKER, S., MEBAZAA, A. (2014). High prevalence of iron deficiency in patients with acute decompensated heart failure. European Journal of Heart Failure, 16(9), 984–991.
  8. DELOUGHERY, T.G. (2017). Iron deficiency anemia. Medical Clinics of North America, 101(2), 319–332.
  9. DINSHAW, L., MÜNCH, J., DICKOW, J., LEZIUS, S., WILLEMS, S., HOFFMANN, B.A., PATTEN, M. (2018). The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy. Clinical Research in Cardiology, 107(2), 130–137.
  10. HEGDE, N., RICH, M.W., GAYOMALI, C. (2006). The cardiomyopathy of iron deficiency. Texas Heart Institute Journal, 33(3), 340–344.
  11. JANKOWSKA, E.A., PONIKOWSKI, P. (2010). Molecular Changes in myocardium in the course of anemia or iron deficiency. Heart Failure Clinics, 6(3), 295–304.
  12. KOBAK, K.A., RADWAŃSKA, M., DZIĘGAŁA, M., KASZTURA, M., JOSIAK, K., BANASIAK, W., PONIKOWSKI, P., JANKOWSKA, E.A. (2019). Structural and functional abnormalities in iron-depleted heart. Heart Failure Reviews, 24(2), 269–277.
  13. LOPEZ, A., CACOUB, P., MACDOUGALL, I.C., PEYRIN